Sienna Biopharmaceuticals Inc - ESG Rating & Company Profile powered by AI
This Disclosure score includes seventeen UN Sustainable Development Goals including: 'Quality Education', 'Industry, Innovation & Infrastructure' and 'Life on Land'. This report of Sienna Biopharmaceuticals Inc employs information from across the web as well as from public documents by Sienna Biopharmaceuticals Inc. The report of Sienna Biopharmaceuticals Inc is assembled by All Street Sevva using proprietary NLP.
Sienna Biopharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | Sienna Biopharmaceuticals Inc | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Sienna Biopharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Sienna Biopharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Sienna Biopharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Sienna Biopharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Sienna Biopharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Sienna Biopharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Sienna Biopharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Sienna Biopharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Sienna Biopharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Sienna Biopharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Sienna Biopharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Sienna Biopharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Sienna Biopharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Sienna Biopharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Sienna Biopharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Sienna Biopharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Sienna Biopharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Sienna Biopharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Sienna Biopharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Sienna Biopharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Sienna Biopharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Sienna Biopharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Sienna Biopharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Sienna Biopharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Sienna Biopharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Sienna Biopharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Sienna Biopharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Sienna Biopharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Sienna Biopharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Sienna Biopharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Sienna Biopharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Sienna Biopharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Sienna Biopharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Sienna Biopharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Sienna Biopharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Sienna Biopharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Sienna Biopharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Sienna Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs in various therapeutic areas. It develops therapies in immunology and inflammation that target select pathways in tissues, such as skin. The company's lead product candidates include SNA-120, a first-in-class inhibitor of tropomyosin receptor kinase A, which is in a Phase IIb clinical trial for the treatment of psoriasis and associated pruritus; and SNA-125, a topical dual Janus kinase 3 inhibitor that is in Phase I/II clinical trials for the treatment of atopic dermatitis, psoriasis, and pruritus. It also develops SNA-001, a topical suspension of silver particles, which is in pivotal clinical trials for the treatment of acne, as well as for the reduction of light-pigmented hair, including white, gray, blonde, light brown, and light red hair. The company was formerly known as Sienna Labs, Inc. and changed its name to Sienna Biopharmaceuticals, Inc. in February 2016. Sienna Biopharmaceuticals, Inc. was founded in 2010 and is headquartered in Westlake Village, California. On December 18, 2019, Sienna Biopharmaceuticals, Inc. filed a voluntary petition for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on September 16, 2019.